These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24470499)

  • 1. Cell contact-dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine response.
    Bartholomaeus P; Semmler LY; Bukur T; Boisguerin V; Römer PS; Tabares P; Chuvpilo S; Tyrsin DY; Matskevich A; Hengel H; Castle J; Hünig T; Kalinke U
    J Immunol; 2014 Mar; 192(5):2091-8. PubMed ID: 24470499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody C region influences TGN1412-like functional activity in vitro.
    Ball C; Fox B; Hufton S; Sharp G; Poole S; Stebbings R; Eastwood D; Findlay L; Parren PW; Thorpe R; Bristow A; Thorpe SJ
    J Immunol; 2012 Dec; 189(12):5831-40. PubMed ID: 23150712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Fcγ receptors compete for TGN1412 binding that determines the antibody's effector function.
    Dudek S; Weißmüller S; Anzaghe M; Miller L; Sterr S; Hoffmann K; Hengel H; Waibler Z
    Eur J Immunol; 2019 Jul; 49(7):1117-1126. PubMed ID: 31002172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of FcγRIIb on monocytes is necessary to promote the superagonist activity of TGN1412.
    Hussain K; Hargreaves CE; Roghanian A; Oldham RJ; Chan HT; Mockridge CI; Chowdhury F; Frendéus B; Harper KS; Strefford JC; Cragg MS; Glennie MJ; Williams AP; French RR
    Blood; 2015 Jan; 125(1):102-10. PubMed ID: 25395427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412.
    Römer PS; Berr S; Avota E; Na SY; Battaglia M; ten Berge I; Einsele H; Hünig T
    Blood; 2011 Dec; 118(26):6772-82. PubMed ID: 21931118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cells co-stimulate peripheral blood mononuclear cell responses to monoclonal antibody TGN1412 in culture.
    Findlay L; Sharp G; Fox B; Ball C; Robinson CJ; Bird C; Stebbings R; Eastwood D; Wadhwa M; Poole S; Thorpe R; Thorpe SJ
    Cytokine; 2011 Jul; 55(1):141-51. PubMed ID: 21493088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials--Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm.
    Vessillier S; Eastwood D; Fox B; Sathish J; Sethu S; Dougall T; Thorpe SJ; Thorpe R; Stebbings R
    J Immunol Methods; 2015 Sep; 424():43-52. PubMed ID: 25960173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A whole blood in vitro cytokine release assay with aqueous monoclonal antibody presentation for the prediction of therapeutic protein induced cytokine release syndrome in humans.
    Wolf B; Morgan H; Krieg J; Gani Z; Milicov A; Warncke M; Brennan F; Jones S; Sims J; Kiessling A
    Cytokine; 2012 Dec; 60(3):828-37. PubMed ID: 22986013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.
    Veri MC; Gorlatov S; Li H; Burke S; Johnson S; Stavenhagen J; Stein KE; Bonvini E; Koenig S
    Immunology; 2007 Jul; 121(3):392-404. PubMed ID: 17386079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation.
    Weissmüller S; Semmler LY; Kalinke U; Christians S; Müller-Berghaus J; Waibler Z
    Blood; 2012 Jun; 119(26):6268-77. PubMed ID: 22577174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple whole blood bioassay detects cytokine responses to anti-CD28SA and anti-CD52 antibodies.
    Bailey L; Moreno L; Manigold T; Krasniqi S; Kropshofer H; Hinton H; Singer T; Suter L; Hansel TT; Mitchell JA
    J Pharmacol Toxicol Methods; 2013; 68(2):231-239. PubMed ID: 23280407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important roles of CD32 in promoting suppression of IL-4 induced immune responses by a novel anti-IL-4Rα therapeutic antibody.
    Zhao J; Jiang L; Deng L; Xu W; Cao Y; Chen C; Yang Y; Wu H; Huang Y; Zhu Z; Huang H
    MAbs; 2019 Jul; 11(5):837-847. PubMed ID: 30950681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of the TGN1412 anti-CD28 monoclonal antibody lower hinge confers specific FcγRIIb binding and retention of super-agonist activity.
    Chenoweth AM; Esparon S; Wines BD; Schuurman J; Labrijn AF; Hogarth PM
    Immunol Cell Biol; 2023 Aug; 101(7):657-662. PubMed ID: 36997299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A predictive biomimetic model of cytokine release induced by TGN1412 and other therapeutic monoclonal antibodies.
    Dhir V; Fort M; Mahmood A; Higbee R; Warren W; Narayanan P; Wittman V
    J Immunotoxicol; 2012; 9(1):34-42. PubMed ID: 22074378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner.
    Vos AC; Wildenberg ME; Duijvestein M; Verhaar AP; van den Brink GR; Hommes DW
    Gastroenterology; 2011 Jan; 140(1):221-30. PubMed ID: 20955706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive
    Ito S; Miwa K; Hattori C; Aida T; Tsuchiya Y; Mori K
    J Immunotoxicol; 2021 Dec; 18(1):136-143. PubMed ID: 34644231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD32 Ligation Promotes the Activation of CD4
    Holgado MP; Sananez I; Raiden S; Geffner JR; Arruvito L
    Front Immunol; 2018; 9():2814. PubMed ID: 30555482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models.
    Yan H; Bhagwat B; Sanden D; Willingham A; Tan A; Knapton AD; Weaver JL; Howard KE
    Toxicol Appl Pharmacol; 2019 Jun; 372():57-69. PubMed ID: 30914376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
    Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of IgG FcR-mediated proliferation of human T cells induced by mouse and human anti-CD3 monoclonal antibodies. Identification of a functional polymorphism to human IgG2 anti-CD3.
    Parren PW; Warmerdam PA; Boeije LC; Capel PJ; van de Winkel JG; Aarden LA
    J Immunol; 1992 Feb; 148(3):695-701. PubMed ID: 1530954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.